esomeprazole

The drug is used for the treatment of gastroesophageal reflux disease (GERD), esophagitis, gastric ulcers (including those caused by anti-inflammatory drugs), as well as for the prevention of recurrent bleeding after endoscopic treatment of ulcers.

Form: lyophilisate for solution for injection

ATC: A02BC05

Manufacturer: Naprod Life Sciences Pvt. Ltd.

The drug is used for the treatment of gastroesophageal reflux disease (GERD) and peptic ulcer disease. It is also used to prevent gastric and duodenal ulcers caused by the use of non-steroidal anti-inflammatory drugs (NSAIDs), and to support the cessation of bleeding following endoscopic treatment of an ulcer.

Form: powder for solution for injection and infusion

ATC: A02BC05

Manufacturer: Aspiron Pharma Limited

The drug is used for the treatment of gastroesophageal reflux disease (GERD), gastric ulcers (including those caused by anti-inflammatory drugs), as well as for the prevention of recurrent bleeding after endoscopic treatment of gastric or duodenal ulcers.

Form: lyophilisate for solution for injection

ATC: A02BC05

Manufacturer: Immacul Lifesciences Private Limited

The drug is used to treat gastroesophageal reflux disease (GERD), esophagitis, as well as for the treatment and prevention of gastric and duodenal ulcers caused by the use of non-steroidal anti-inflammatory drugs (NSAIDs). It is also used to support the cessation of bleeding following endoscopic treatment of ulcers.

Form: powder for solution for injection and infusion

ATC: A02BC05

Manufacturer: Farmex Group LLC

The drug is used for antisecretory therapy (reducing acidity) when oral administration is not possible. It is prescribed for gastroesophageal reflux disease (GERD) with esophagitis or severe reflux symptoms, for the treatment of gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs), as well as to support hemostasis and prevent recurrent bleeding following endoscopic treatment of ulcers.

Form: powder for solution for injection and infusion

ATC: A02BC05

Manufacturer: Steril-Jen Life Sciences (P) Ltd

The drug is used for the treatment of gastroesophageal reflux disease (GERD), gastric ulcers (particularly those caused by non-steroidal anti-inflammatory drugs (NSAIDs)), as well as for the prevention of recurrent bleeding following endoscopic treatment of ulcers.

Form: powder for injection solution or infusion solution

ATC: A02BC05

Manufacturer: Sofarimex – Industria Chimica e Farmaceutica, S.A. (full-cycle manufacturing)

The drug is used for the treatment of gastroesophageal reflux disease (GERD), gastric ulcers (including those caused by non-steroidal anti-inflammatory drugs, NSAIDs), and for the prevention of recurrent bleeding following endoscopic treatment of gastric or duodenal ulcers.

Form: powder for solution for injection and infusion

ATC: A02BC05

Manufacturer: Aspiron Pharma Limited

The drug is used for the treatment of gastroesophageal reflux disease (GERD), erosive reflux esophagitis, as well as for the treatment and prevention of gastric and duodenal ulcers caused by the use of non-steroidal anti-inflammatory drugs (NSAIDs). It is also used to support the cessation of bleeding following endoscopic treatment of ulcers.

Form: powder for solution for injection and infusion

ATC: A02BC05

Manufacturer: NOBEL ILAC SANAYI VE TICARET A.S.

The drug is used for the treatment of erosive reflux esophagitis, prevention of esophagitis recurrence, and symptomatic treatment of gastroesophageal reflux disease (GERD). It is also used for the treatment of gastric and duodenal ulcers (including those caused by Helicobacter pylori or the use of anti-inflammatory drugs), Zollinger–Ellison syndrome, and for the prevention of ulcer bleeding.

Form: tablets, enteric-coated

ATC: A02BC05

Manufacturer: Hetero Labs Limited

The drug is used for the treatment of erosive reflux esophagitis, the prevention and treatment of gastric and duodenal ulcers (including those caused by non-steroidal anti-inflammatory drugs or Helicobacter pylori bacteria), as well as for the treatment of Zollinger–Ellison syndrome.

Form: tablets, enteric-coated

ATC: A02BC05

Manufacturer: Hetero Labs Limited

The drug is used to treat erosive reflux esophagitis (a part of gastroesophageal reflux disease), to prevent recurrent bleeding from ulcers, and to treat Zollinger-Ellison syndrome. In children aged 12 years and older, it is prescribed for the treatment of erosive reflux esophagitis.

Form: tablets, enteric-coated

ATC: A02BC05

Manufacturer: LAMP San Prospero S.p.A. (batch release, primary and secondary packaging)

The drug is used for the treatment of gastroesophageal reflux disease (GERD), esophagitis, as well as for the treatment and prevention of gastric and duodenal ulcers (particularly those caused by the use of non-steroidal anti-inflammatory drugs (NSAIDs)). It is also used to support the cessation of bleeding following endoscopic treatment of ulcers.

Form: powder for solution for injection and infusion

ATC: A02BC05

Manufacturer: JSC "Farmak" (manufacturing and packaging in bulk of the product of the manufacturer Laboratorios Normon S.A., Spain)

The drug is used for the treatment of erosive reflux esophagitis, prevention of its recurrence, and symptomatic treatment of gastroesophageal reflux disease (GERD). It is also used for the treatment of Helicobacter pylori-induced duodenal ulcers, for the prevention of gastric ulcers during long-term use of non-steroidal anti-inflammatory drugs (NSAIDs), and in Zollinger–Ellison syndrome.

Form: tablets, enteric-coated

ATC: A02BC05

Manufacturer: JSC "Farmak" (manufacturing and packaging in bulk for the manufacturer Balkanpharma Dupnitsa AD, Bulgaria)

The drug is used for the treatment of erosive reflux esophagitis, prevention of its recurrence, and symptomatic treatment of gastroesophageal reflux disease (GERD). It is also used for the treatment of duodenal ulcers (caused by Helicobacter pylori), prevention of gastric ulcers during long-term use of non-steroidal anti-inflammatory drugs (NSAIDs), and for the treatment of Zollinger–Ellison syndrome.

Form: tablets, enteric-coated

ATC: A02BC05

Manufacturer: JSC "Farmak" (manufacturing and packaging in bulk for the manufacturer Balkanpharma Dupnitsa AD, Bulgaria)

The drug is used to reduce gastric acid secretion. It is prescribed to adults for gastroesophageal reflux disease (GERD), the treatment of gastric ulcers (particularly those caused by anti-inflammatory drugs), and for the prevention of recurrent bleeding after endoscopic treatment of ulcers. For children aged 1 to 18 years, the drug is prescribed for the treatment of GERD if tablets cannot be administered.

Form: powder for solution for injection and infusion

ATC: A02BC05

Manufacturer: VEM Ilac San. ve Tik. A.S.

The drug is used to reduce gastric acid secretion. It is prescribed to adults for gastroesophageal reflux disease (GERD), the treatment of gastric ulcers (including those related to NSAID use), and to prevent rebleeding after endoscopic treatment of ulcers. For children aged 1 to 18 years, the drug is prescribed for GERD if oral administration is not possible.

Form: powder for solution for injection and infusion

ATC: A02BC05

Manufacturer: Immacul Lifesciences Private Limited

The drug is used to reduce gastric acid secretion. It is prescribed to adults for gastroesophageal reflux disease (GERD), esophagitis, gastric ulcers (including those caused by anti-inflammatory drugs), and for the prevention of recurrent bleeding after ulcer treatment. For children aged 1 to 18 years, it is prescribed for GERD if medication in tablet form cannot be administered.

Form: powder for solution for injection and infusion

ATC: A02BC05

Manufacturer: Laboratorios Normon S.A. (manufacturing, packaging, control and batch release of medicinal product)

The drug is used for the treatment of gastroesophageal reflux disease (GERD), esophagitis, gastric ulcers (including those caused by anti-inflammatory drugs), and for the prevention of recurrent bleeding after endoscopic treatment of ulcers.

Form: powder for solution for injection and infusion

ATC: A02BC05

Manufacturer: AstraZeneca AB (manufacturing, testing, primary packaging, release of unpackaged medicinal product, secondary packaging and release of finished medicinal product)

The drug is used for the treatment of erosive reflux esophagitis, symptomatic treatment of gastroesophageal reflux disease (GERD), and to prevent recurrences of esophagitis. It is also prescribed for the treatment and prevention of gastric and duodenal ulcers caused by the use of anti-inflammatory drugs (NSAIDs), and for the eradication of Helicobacter pylori bacteria (in combination with antibiotics). Additionally, the drug is used in Zollinger–Ellison syndrome.

Form: tablets, film-coated

ATC: A02BC05

Manufacturer: AstraZeneca AB (manufacturing, quality control, packaging, labeling/storage and batch release of finished medicinal product)

The drug is used for the treatment of erosive reflux esophagitis (a component of gastroesophageal reflux disease), the prevention of recurrent ulcer bleeding, and for the treatment of Zollinger-Ellison syndrome. In adults and children from 12 years of age, it is also prescribed for erosive reflux esophagitis.

Form: tablets, film-coated

ATC: A02BC05

Manufacturer: AstraZeneca AB (manufacturing, quality control, packaging, labeling/storage and batch release of finished medicinal product)

The drug is used for gastric antisecretory therapy (reduction of acidity) when oral administration is not possible. It is prescribed for gastroesophageal reflux disease (GERD), the treatment of NSAID-induced gastric ulcers, and for the prevention of recurrent bleeding following endoscopic ulcer treatment.

Form: powder for solution for injection and infusion

ATC: A02BC05

Manufacturer: Laboratorios Normon S.A.

The drug is used for the treatment of erosive reflux esophagitis, symptomatic treatment of gastroesophageal reflux disease (GERD), and to prevent recurrences of esophagitis. It is also prescribed for the eradication of Helicobacter pylori (in combination with antibiotics), the treatment of gastric and duodenal ulcers caused by the use of non-steroidal anti-inflammatory drugs (NSAIDs), and in Zollinger-Ellison syndrome.

Form: tablets, coated, enteric-coated

ATC: A02BC05

Manufacturer: Torrent Pharmaceuticals Ltd

The drug is used for the treatment of erosive reflux esophagitis, symptomatic treatment of gastroesophageal reflux disease (GERD), and to prevent recurrences of esophagitis. It is also used for the eradication of Helicobacter pylori (in combination with antibiotics), the treatment of gastric and duodenal ulcers caused by the use of non-steroidal anti-inflammatory drugs (NSAIDs), as well as in Zollinger-Ellison syndrome.

Form: tablets, coated, enteric-coated

ATC: A02BC05

Manufacturer: Torrent Pharmaceuticals Ltd

The drug is used for the treatment of erosive reflux esophagitis, symptomatic treatment of gastroesophageal reflux disease (GERD), as well as for the prevention and treatment of gastric and duodenal ulcers (including those caused by Helicobacter pylori or the use of non-steroidal anti-inflammatory drugs (NSAIDs)). It is also used in Zollinger-Ellison syndrome.

Form: tablets, enteric-coated

ATC: A02BC05

Manufacturer: San Pharmaceutical Industries Limited

The drug is used for the treatment of erosive reflux esophagitis, symptomatic treatment of gastroesophageal reflux disease, and to prevent its recurrence. It is also used for the treatment and prevention of ulcers caused by long-term use of non-steroidal anti-inflammatory drugs (NSAIDs), for the eradication of Helicobacter pylori (in combination with antibiotics), and in Zollinger-Ellison syndrome.

Form: tablets, enteric-coated

ATC: A02BC05

Manufacturer: San Pharmaceutical Industries Limited

The drug is used to reduce gastric acid secretion. It is prescribed to adults for gastroesophageal reflux disease (GERD), esophagitis, as well as for the treatment and prevention of gastric and duodenal ulcers caused by the use of anti-inflammatory drugs (NSAIDs). It is also used to support the cessation of bleeding following endoscopic ulcer treatment.

Form: powder, lyophilized for solution for injection and infusion

ATC: A02BC05

Manufacturer: San Pharmaceutical Industries Ltd.

The drug is used to reduce gastric acid secretion. It is prescribed to adults for reflux disease (GERD), esophagitis, the treatment of gastric ulcers (including those caused by anti-inflammatory drugs), and for the prevention of recurrent bleeding after endoscopic treatment of ulcers. For children aged 1 to 18 years, the drug is prescribed for the treatment of GERD if tablets cannot be administered.

Form: lyophilisate for solution for injection

ATC: A02BC05

Manufacturer: Mefar Ilac San. A.S.

The drug is used to reduce gastric acid secretion. It is prescribed to adults for reflux disease (GERD), gastric ulcers (including those caused by anti-inflammatory drugs), and for the prevention of recurrent bleeding after ulcer treatment. For children aged 1 to 18 years, the drug is prescribed for erosive reflux esophagitis or severe reflux symptoms if oral administration is not possible.

Form: powder for solution for injection and infusion

ATC: A02BC05

Manufacturer: WORLD MEDICINE ILAC SAN. VE TIC. A.S.

The drug is used for the treatment of gastroesophageal reflux disease (GERD), esophagitis, as well as for the treatment and prevention of gastric and duodenal ulcers caused by the use of non-steroidal anti-inflammatory drugs (NSAIDs). It is also used to support hemostasis and prevent rebleeding after endoscopic treatment of ulcers.

Form: lyophilisate for solution for injection

ATC: A02BC05

Manufacturer: Steril-Jen Life Sciences (P) Ltd

The drug is used for the treatment of erosive reflux esophagitis, prevention of its recurrence, and symptomatic treatment of gastroesophageal reflux disease (GERD). It is also used for the treatment of gastric and duodenal ulcers (including those caused by Helicobacter pylori), in Zollinger-Ellison syndrome, and for the prevention of ulcers in patients on long-term anti-inflammatory drug (NSAID) therapy.

Form: tablets, enteric-coated

ATC: A02BC05

Manufacturer: Hetero Labs Limited

The drug is used for the treatment of erosive reflux esophagitis, prevention of its recurrence, and symptomatic treatment of gastroesophageal reflux disease (GERD). It is also used for the treatment of gastric and duodenal ulcers (including those caused by Helicobacter pylori or the use of anti-inflammatory drugs), Zollinger-Ellison syndrome, and for the prevention of bleeding.

Form: tablets, enteric-coated

ATC: A02BC05

Manufacturer: Hetero Labs Limited